Search results for "INACTIVATION"

showing 10 items of 81 documents

Detoxication of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione.

1998

AbstractEpidemiological studies suggest that individuals differing in the expression of allelic variants of the human glutathione transferase (GST) Pi gene differ in susceptibility to chemical carcinogens such as polycyclic aromatic hydrocarbons (PAH). This study reports the catalytic efficiencies (kcat/Km) of two naturally occurring variants, GSTP1-1/I-105 and GSTP1-1/V-105, towards a series of fjord-region diol epoxides representing potent biologically active PAH metabolites, and two GSTP1-1 mutants with Ala105 and Trp105 in the active site. The results indicate that individuals who are homozygous for the allele encoding GSTP1-1/V-105 might be more susceptible to PAH carcinogenesis due to…

StereochemistryCarcinogenesisMutantBiophysicsPolycyclic aromatic hydrocarbonurologic and male genital diseasesBiochemistryCatalysischemistry.chemical_compoundStructure-Activity RelationshipStructural BiologyGeneticspolycyclic compoundsStructure–activity relationshipHumansGlutathione conjugationPolycyclic Aromatic HydrocarbonsMolecular BiologyGeneneoplasmsCarcinogenGlutathione Transferasechemistry.chemical_classificationbiologyMolecular StructureChemistryActive siteGenetic VariationBiological activityCell BiologyGlutathioneGlutathioneFjord regionPolycyclic aromatic hydrocarbonKineticsBiochemistryDiol epoxideHuman glutathione transferase P1-1Inactivation Metabolicbiology.proteinCarcinogensFEBS letters
researchProduct

Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin

2021

Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique o…

Time FactorsCancer TreatmentMetal Nanoparticleslcsh:MedicinePharmacologyMiceNanotechnologyTissue Distributionlcsh:Sciencemedia_commonDrug DistributionDrug CarriersMultidisciplinaryChemistryDNA NeoplasmOrgan SizeHydrogen-Ion ConcentrationEndocytosisOncologyColloidal goldDrug deliveryInactivation MetabolicMedicinemedicine.drugResearch ArticleBiotechnologyDrugBiodistributionDrugs and Devicesmedia_common.quotation_subjectMaterials ScienceAntineoplastic AgentsMaterial by AttributePharmacokineticsCell Line TumormedicineAnimalsHumansPharmacokineticsBiologyNanomaterialsCisplatinUnited States Food and Drug Administrationlcsh:RChemotherapy and Drug TreatmentUnited StatesBionanotechnologylcsh:QGoldNanocarriersCisplatinConjugate
researchProduct

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxin

2005

Zearalenone (ZEA) is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. It is frequently implicated in reproductive disorders of farm animals and occasionally in hyperoestrogenic syndromes in humans. There is evidence that ZEA and its metabolites possess oestrogenic activity in pigs, cattle and sheep. However, ZEA is of a relatively low acute toxicity after oral or interperitoneal administration in mice, rat and pig. The biotransformation for ZEA in animals involves the formation of two metabolites alpha-zearalenol (alpha-ZEA) and beta-zearalenol (beta-ZEA) which are subsequently conjugated with glucuronic acid. Moreover, ZEA has also been shown to be h…

Tolerable daily intakeAnimal feedDevelopmental toxicityBiologyGlobal HealthToxicologyToxicologyEatingchemistry.chemical_compoundToxicity TestsAnimalsHumansEstrogens Non-SteroidalMycotoxinZearalenoneChronic toxicityTraditional medicinefungiMycotoxicosisfood and beveragesGeneral MedicineAnimal FeedAcute toxicitychemistryInactivation MetabolicToxicityFood MicrobiologyZearalenoneFood ScienceFood and Chemical Toxicology
researchProduct

High pressure treatment and green tea extract synergistically control enteric virus contamination in beverages

2022

Consumers are driving food production toward the use of natural preservatives and minimal processing technologies. Green tea extract (GTE) at low concentration could be combined with high pressure processing (HPP) for reduced treatment times and quality impact on foods in a hurdle concept for synergistic effects on foodborne viral pathogens, specifically human norovirus and hepatitis A virus (HAV). Viral inactivation by HPP (at 300, 400, and 500 MPa for 5 min) combined with 3.3 mg/mL aged-GTE was initially evaluated in buffer (PBS) against murine norovirus (MNV), a culturable human norovirus surrogate, and HAV. Furthermore, human norovirus inactivation was evaluated by the novel human intes…

Viral inactivationHurdle technologyMicrobiologiaHuman norovirusHepatitis A virusEnteric virusHuman intestinal enteroidFood ScienceBiotechnologyFood safetyEcologia
researchProduct

Activity investigation of pinostrobin towards herpes simplex virus-1 as determined by atomic force microscopy

2009

In the present study, the antiviral activity of pinostrobin towards herpes simplex virus-1 (HSV-1) was investigated by MTT assay and atomic force microscopy. Pinostrobin can inhibit HSV-1 replication with 50% effective concentration (EC(50)) of 22.71 ± 1.72 μg/ml. MTT assay showed HSV-1 was significantly inhibited when pretreated with pinostrobin, with the inhibition of 85.69 ± 2.59%. Significant changes in morphology and size of HSV-1 were observed by atomic force microscopy (AFM) in response to pinostrobin treatment. AFM topography and phase images showed that with increasing time, the envelope was shedded and damaged, finally leading to virus inactivation. With increasing concentration, …

Virus inactivationPharmaceutical ScienceMice Inbred StrainsHerpesvirus 1 HumanMicrobial Sensitivity TestsMicroscopy Atomic Forcemedicine.disease_causePhase imageMiceIn vivoChlorocebus aethiopsDrug DiscoverymedicineAnimalsMTT assayTreatment effectVero CellsPharmacologyPlant ExtractsChemistryAtomic force microscopyHerpes SimplexVirologyHerpes simplex virusComplementary and alternative medicineFlavanonesBiophysicsVero cellMolecular MedicinePhytotherapyPhytomedicine
researchProduct

Effect of the pea (Pisum sativum L.) gene PsSym36 on Glomus intraradices gene expression

2007

International audience; The Pisum sativum L. mutant RisNod24 (Pssym36) is defective for arbuscular mycorrhiza formation in late stages of AM. Recent studies identified some plant genes up- and down- regulated at stage of arbuscular development using pea mutant RisNod24, but nothing is still known about fungal gene inactivation. To investigate effect of PsSym36 pea gene on fungal gene expression, Glomus intraradices genes which have been previously identified as markers of successful symbiosis development (Seddas et al., unpublished results) were chosen. List of AM genes used in this study: signalling, transcription, protein turn-over (RHO/GDP dissociation inhibitor, Peptidylprolyl isomerase…

[SDV] Life Sciences [q-bio]GLOMUS INTRARADICESFUNGAL GENE INACTIVATION[SDV]Life Sciences [q-bio]PISUM SATIVUM L.PEA MUTANT RISNOD24PSSYM36
researchProduct

High-Temperature Short-Time Inactivation of Peroxidase by Direct Heating with a Five-Channel Computer-Controlled Thermoresistometer

1997

The thermal inactivation kinetics of horseradish and asparagus peroxidase in high-temperature short-time conditions was studied by heating in a five-channel computer-controlled thermoresistometer. Horseradish peroxidase was heated between 111.5 and 145°C and the reaction was analyzed assuming that two isoenzymes with EaL = 44.1 and Eas = 22.0 kcal/mol were present. Asparagus peroxidase heated from 110 to l20°C reacted with first-order kinetics, with Ea = 20 kcal/mol. The five-channel computer-controlled thermoresistometer enabled us to study the inactivation kinetics of the more labile fraction of horseradish peroxidase at temperatures above 100°C; this equipment was suitable for studying t…

biologyChemistryInactivation kineticsKineticsHeat resistancebiology.organism_classificationMicrobiologyHorseradish peroxidaseBiochemistrybiology.proteinDirect heatingHorse-radishAsparagusFood SciencePeroxidaseNuclear chemistryJournal of food protection
researchProduct

Metabolic Inactivation of Reactive Metabolites

1978

ABSTRACT Many compounds which are not electrophilically reactive as such are transformed by mammalian enzymes to reactive metabolites which are, in many cases, responsible for cytotoxic, mutagenic and/or carcinogenic effects of the compounds in question. The essential role of activating systems in this situation has become common knowledge during the last decade. However, many reactive metabolites are also subject to inactivation by mammalian enzymes. This important parameter is frequently not taken into account. Compounds possessing aromatic or olefinic moieties are very widely occurring and activation of these often proceeds via an electrophilically reactive epoxide. This may be transform…

chemistry.chemical_classificationchemistry.chemical_compoundCytosolEnzymechemistryMetabolic InactivationBiochemistryStereochemistryEpoxidePyreneGlutathioneMonooxygenaseCarcinogen
researchProduct

Comment: Why are females with Fabry disease affected?

2019

medicine.medical_specialtyHunter Syndromebusiness.industryHunter syndromemedicine.diseaseLysosomal Storage DisorderFabry diseaseEndocrinologyEndocrinologyInternal medicineGeneticsmedicineFabry DiseaseX-inactivationX-linked DisorderbusinessMolecular BiologyLetter to the Editor
researchProduct

Disease manifestations and X inactivation in heterozygous females with Fabry disease

2006

Aim: Fabry disease is an X-linked lysosomal storage disorder characterized by an accumulation of neutral glycosphingolipids in multiple organ systems caused by α-galactosidase A deficiency due to mutations in the GLA gene. The majority of heterozygous females show the characteristic signs and symptoms of the disease, and some of them are severely affected. The current hypothesis for the occurrence of disease manifestations in females is skewed X inactivation favouring the mutant GLA allele. Method: We analyzed the patterns of X inactivation in the leukocytes of 28 biochemically and genetically characterized symptomatic Fabry disease heterozygotes and their correlation with clinical and bioc…

medicine.medical_specialtyPathologyMutantHeterozygote advantageGeneral MedicineDiseaseBiologymedicine.diseaseFabry diseaseX-inactivationEndocrinologyInternal medicinePediatrics Perinatology and Child HealthGenotypemedicineAlleleSkewed X-inactivationActa Paediatrica
researchProduct